Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Connective tissue diseases

Is combined oral contraceptive use linked to SLE incidence?

The link between exposure to exogenous estrogen and the incidence of systemic lupus erythematosus is controversial, but new data suggest that the use of combined oral contraceptives could increase the risk of developing the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mok, C. C. & Lau, C. S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56, 481–490 (2003).

    Article  CAS  Google Scholar 

  2. Bernier, M. O., Mikaeloff, Y., Hudson, M. & Suissa, S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 61, 476–481 (2009).

    Article  CAS  Google Scholar 

  3. Sanchez-Guerrero, J., Karlson, E. W., Liang, M. H., Hunter, D. J., Speizer, F. E. & Colditz, G. A. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 40, 804–808 (1997).

    Article  CAS  Google Scholar 

  4. Costenbader, K. H., Feskanich, D., Stampfer, M. J. & Karlson, E. W. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 56, 1251–1262 (2007).

    Article  Google Scholar 

  5. Kanda, N., Tsuchida, T. & Tamaki, K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 42, 328–337 (1999).

    Article  CAS  Google Scholar 

  6. Guballa, N., Sammaritano, L., Schwartzman, S., Buyon, J. & Lockshin, M. D. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 43, 550–556 (2000).

    Article  CAS  Google Scholar 

  7. Buyon, J. P. et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142, 953–962 (2005).

    Article  CAS  Google Scholar 

  8. Petri, M. et al. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 353, 2550–2558 (2005).

    Article  CAS  Google Scholar 

  9. Sánchez-Guerrero, J. et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N. Engl. J. Med. 353, 2539–2549 (2005).

    Article  Google Scholar 

  10. Lee, Y. J. et al. Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann. Rheum. Dis. 63, 1244–1249 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mok, C. Is combined oral contraceptive use linked to SLE incidence?. Nat Rev Rheumatol 5, 360–361 (2009). https://doi.org/10.1038/nrrheum.2009.118

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2009.118

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing